BioSpace News Archive

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the Company’s CEO John W. Huemoeller II will be presenting at the 13th Annual LD Micro Main Event investor conference on Monday, December 14, 2020, at 11:00 a.m. PST/2:00 p.m. EST. During the 10-minute presentation, Huemoeller will discuss AXIM’

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem GmbH have verified that one of their recently discovered compounds is similar in potency to remdesivir, the only approved anti-viral drug agains

Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has sold over 10 million of its Logix Smart™ COVID-19 Test Kits to its domestic and international network of laboratories, hospitals, and distributors.

Moderna, Inc. , (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today confirmed that the Company concluded an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19

Bionexus Gene Lab Corp (OTCMKTS: BGLC), based in Kuala Lumpur, Malaysia, focused on Risk stratification of cancer, today announced that Dr. Stephen Ponnampalam, Chief Medical Officer, will present live at LifeSciencesInvestorForum.com on December 17 th . DATE: Thursday, December 17 th TIME: 12:00 PM ET LINK: https://bit.ly/3mPSVkO This will be a live, interactive online event where investors are invited to ask the

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recently voted to approve Emergency Use Authorization of BioNTech and Pfizer’s Covid-19 vaccine despite recent reports of anaphylactic reactions among recipients. The vaccine contains polyethylene glycol (PEG) which has been ide

Enzolytics, Inc. (OTC PINK:ENZC or the has engaged SAMM SOLUTIONS, INC. (DBA BTS Research), through a Master Service Agreement to conduct a toxicity study on the Companys Flagship compound ITV-1.

GE Current, a Daintree company, has completed in-situation testing of its 365DisInFx™ UVC disinfection technology LPU series devices utilizing the aerosolized virus, bacteriophage MS2

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD Micro Main Event Conference on Tuesday, December 15, 2020 at 11:00 AM Pacific Time. Additionally, the Company will host a video webcast with the investment community on Thu